We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+7.23%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$17.7B
AUM Growth
-$2.27B
Cap. Flow
-$3.05B
Cap. Flow %
-17.25%
Top 10 Hldgs %
15.77%
Holding
1,947
New
557
Increased
335
Reduced
444
Closed
606

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$113M
2
BERY
Berry Global Group, Inc.
BERY
+$106M
3
MRK icon
Merck
MRK
+$95.9M
4
BIDU icon
Baidu
BIDU
+$85.8M
5
IQV icon
IQVIA
IQV
+$83.1M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$229M
2
LVS icon
Las Vegas Sands
LVS
+$150M
3
BABA icon
Alibaba
BABA
+$131M
4
C icon
Citigroup
C
+$130M
5
MU icon
Micron Technology
MU
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 24.85%
2 Technology 15.39%
3 Consumer Discretionary 13.45%
4 Industrials 10.48%
5 Financials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNX icon
1426
CNX Resources
CNX
$5.2B
-1,712,653
Closed -$26.4M
CPA icon
1427
Copa Holdings
CPA
$5.8B
-163,597
Closed -$21M
CPK icon
1428
Chesapeake Utilities
CPK
$3.21B
-8,625
Closed -$607K
CPRI icon
1429
Capri Holdings
CPRI
$1.74B
-67,955
Closed -$4.22M
CPT icon
1430
Camden Property Trust
CPT
$11.3B
-12,882
Closed -$1.08M
CQP icon
1431
Cheniere Energy
CQP
$31.3B
-42,166
Closed -$1.23M
CRBP icon
1432
Corbus Pharmaceuticals
CRBP
$190M
-360
Closed -$66K
CRS icon
1433
Carpenter Technology
CRS
$28.4B
-125,924
Closed -$5.56M
CRSP icon
1434
CRISPR Therapeutics
CRSP
$5.17B
-476,762
Closed -$21.8M
CRUS icon
1435
Cirrus Logic
CRUS
$6.26B
-111,425
Closed -$4.53M
CTRN icon
1436
Citi Trends
CTRN
$605M
-33,744
Closed -$1.04M
CUBE icon
1437
CubeSmart
CUBE
$9.41B
-288,561
Closed -$8.14M
CVLG icon
1438
Covenant Logistics
CVLG
$872M
-28,968
Closed -$432K
CWT icon
1439
California Water Service
CWT
$3.12B
-68,325
Closed -$2.54M
CXW icon
1440
CoreCivic
CXW
$3.19B
-119,090
Closed -$2.33M
D icon
1441
Dominion Energy
D
$59.3B
-185,398
Closed -$12.5M
DAR icon
1442
Darling Ingredients
DAR
$9.44B
-30,337
Closed -$525K
DBX icon
1443
Dropbox
DBX
$8.12B
-72,588
Closed -$2.27M
DCI icon
1444
Donaldson
DCI
$11.4B
-13,901
Closed -$626K
DDS icon
1445
Dillards
DDS
$9.56B
-32,259
Closed -$2.59M
DELL icon
1446
Dell
DELL
$293B
-145,508
Closed -$2.99M
DEO icon
1447
Diageo
DEO
$53.6B
-208,164
Closed -$28.2M
DESP
1448
DELISTED
Despegar.com
DESP
-20,836
Closed -$651K
DFIN icon
1449
Donnelley Financial Solutions
DFIN
$1.16B
-61,547
Closed -$1.06M
DHT icon
1450
DHT Holdings
DHT
$3.02B
-25,748
Closed -$88K

Similar funds

Marshall Wace North America's Q2 2018 Portfolio in Review

As of Q2 2018, Marshall Wace North America held 1,947 positions worth $17.7B, down 11% from $20B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America withdrew a net $3.05B in Q2 2018, closing 606 positions and reducing 444 holdings. Its most notable exit was Time Warner Inc, an estimated $63.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in IQVIA worth $83.1M.

  • Marshall Wace North America's largest Q2 2018 buy was IQVIA: 832,159 shares worth $83.1M.
  • Marshall Wace North America added most to Vertex Pharmaceuticals in Q2 2018, an estimated $113M increase.
  • Marshall Wace North America's biggest Q2 2018 reduction was Johnson & Johnson, cutting an estimated $229M.
  • Marshall Wace North America fully exited Time Warner Inc in Q2 2018, selling an estimated $63.3M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $17.7B portfolio in Q2 2018.
  • Marshall Wace North America opened 557 new positions and closed 606 in Q2 2018.
  • Marshall Wace North America's portfolio value fell 11% quarter-over-quarter to $17.7B.

Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.